An illustration of the drug rapamycin (red) inhibiting the protein complex mTORC1, which has various effects on cellular function
SCIENCE PHOTO LIBRARY/Getty Images
A recent study has shown that the drug rapamycin may have similar effects on extending lifespan as calorie restriction, shedding light on potential interventions to combat ageing. Researchers have long been exploring various methods, including dietary changes and pharmaceuticals, to enhance longevity and mitigate age-related health issues.
Caloric restriction, a well-known approach to extending lifespan in non-human animals, has been a subject of interest in the scientific community. In addition, drugs like rapamycin, initially developed for immunosuppression, have shown promise in prolonging life. Recent studies have even demonstrated that a combination of rapamycin and the cancer drug trametinib could increase the lifespan of mice by up to 30 percent.
Examining data from 167 studies across eight vertebrate species, researchers found that both dietary restriction and rapamycin had a significant impact on extending lifespan in various species. However, while rapamycin shows promise, caution is advised due to its potential side effects, especially at higher doses.
Although the findings are promising, experts emphasize the need for further research before recommending the use of rapamycin or similar drugs for anti-ageing purposes. It is crucial to understand the potential risks and benefits, especially in humans, to make informed decisions about interventions to combat ageing.
While rapamycin and related drugs hold potential, ongoing research is essential to determine their efficacy and safety in extending lifespan. As the quest for anti-ageing interventions continues, scientists are hopeful that future developments in this field will offer new insights into promoting healthy ageing.
